Comunicati stampa

FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients

Edwards Lifesciences Comments on TAVR National Coverage Decision